Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Hi-Tech Pharmacal has acquired rights to Cormax brand from Watson Laboratories for an undisclosed sum of money, under the signed definitive agreement.
Subscribe to our email newsletter
Cormax is a branded version of clobetasol propionate topical solution 0.05%.
Cormax is indicated for the treatment of dermatoses of the scalp.
Hi-Tech Pharmacal president and CEO David Seltzer said since the company will manufacture Cormax for its subsidiary, ECR Pharmaceuticals, it anticipates the product will generate high margins.
"We are pleased to add another well-recognized brand to the ECR portfolio of branded products," Seltzer added.